tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

UK restricts use of Valneva chikungunya vaccine for safety review
The FlyUK restricts use of Valneva chikungunya vaccine for safety review
28d ago
VALN
Valneva drops 2% to $6.05 after UK restricts vaccine use
PremiumThe Fly
Valneva drops 2% to $6.05 after UK restricts vaccine use
28d ago
VALN
Valneva says IXCHIQ ‘well tolerated’ by children ages 1-11 years
PremiumThe Fly
Valneva says IXCHIQ ‘well tolerated’ by children ages 1-11 years
1M ago
VALN
Valneva’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Valneva’s Earnings Call: Growth Amid Challenges
2M ago
Valneva price target lowered to $14 from $15 at Guggenheim
PremiumThe Fly
Valneva price target lowered to $14 from $15 at Guggenheim
2M ago
VALN
Valneva says EMA started Ixchiq review after reports of SAEs
PremiumThe FlyValneva says EMA started Ixchiq review after reports of SAEs
2M ago
VALN
Valneva’s Vaccine Approval and Strategic Partnerships Drive Buy Rating with Promising Financial Projections
Premium
Ratings
Valneva’s Vaccine Approval and Strategic Partnerships Drive Buy Rating with Promising Financial Projections
3M ago
VALN
Valneva granted marketing authorization for Ixchiq in Brail
Premium
The Fly
Valneva granted marketing authorization for Ixchiq in Brail
3M ago
VALN
Positive Outlook for Valneva Driven by Promising Vaccine Pipeline and Strategic Developments
PremiumRatings
Positive Outlook for Valneva Driven by Promising Vaccine Pipeline and Strategic Developments
3M ago
VALN
Valneva granted EC marketing authorization for Ixchiq vaccine
PremiumThe Fly
Valneva granted EC marketing authorization for Ixchiq vaccine
3M ago
VALN
Valneva’s Strategic Advancements and Promising Projections Drive Buy Rating with $17 Target
PremiumRatings
Valneva’s Strategic Advancements and Promising Projections Drive Buy Rating with $17 Target
3M ago
VALN
Valneva renews sales agreement in connection with existing at-the-market program
PremiumThe Fly
Valneva renews sales agreement in connection with existing at-the-market program
3M ago
VALN
Valneva to provide 40,000 IXCHIQ doses in France starting early April
PremiumThe FlyValneva to provide 40,000 IXCHIQ doses in France starting early April
3M ago
VALN
Valneva files prospectus for sale of up to $350M shares
Premium
The Fly
Valneva files prospectus for sale of up to $350M shares
3M ago
VALN
Valneva price target lowered to $15 from $17 at Guggenheim
Premium
The Fly
Valneva price target lowered to $15 from $17 at Guggenheim
4M ago
VALN
Valneva’s Earnings Call Highlights Robust Growth Amid Challenges
PremiumCompany Announcements
Valneva’s Earnings Call Highlights Robust Growth Amid Challenges
4M ago
Positive Outlook for Valneva Driven by Promising Vaccine Developments and Market Opportunities
PremiumRatings
Positive Outlook for Valneva Driven by Promising Vaccine Developments and Market Opportunities
4M ago
VALN
0OB3 Earnings this Week: How Will it Perform?
PremiumPre-Earnings
0OB3 Earnings this Week: How Will it Perform?
4M ago
Valneva reports positive CHMP opinion for adolescent label extension for Ixchiq
PremiumThe Fly
Valneva reports positive CHMP opinion for adolescent label extension for Ixchiq
4M ago
VALN
Valneva’s Promising Growth and Strategic Positioning: Buy Rating Affirmed by Edward White
PremiumRatingsValneva’s Promising Growth and Strategic Positioning: Buy Rating Affirmed by Edward White
5M ago
VALN
Valneva price target lowered to $17 from $18 at H.C. Wainwright
Premium
The Fly
Valneva price target lowered to $17 from $18 at H.C. Wainwright
5M ago
VALN
Valneva jumps 19% after chikungunya vaccine wins UK approval
Premium
The Fly
Valneva jumps 19% after chikungunya vaccine wins UK approval
5M ago
VALN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >